Read More

Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy

Asahi Kasei's $1.1 billion acquisition of Calliditas Therapeutics offers 208 SEK per share in cash. The deal boosts Asahi Kasei's global presence in immunology and renal disease markets, aligning with its strategic growth and expansion in the U.S. and Europe.

CALT

Read More

What’s Going On With T-Mobile Stock Tuesday?

T-Mobile announced Tuesday that it will acquire nearly all of UScellular's wireless operations for approximately $4.4 billion, including UScellular's wireless customers and stores. The deal will expand T-Mobile's network to millions of new customers including those in underserved rural areas.

TMUS